United Therapeutics Corp UTHR:NASDAQ

Last Price$81.97NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/15/19

Today's Change+0.72(0.89%)
Bid (Size)$78.16 (1)
Ask (Size)$86.20 (10)
Day Low / High$81.26 - 82.27
Volume510.9 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 10/15/2019

 

United Therapeutics Corp ( NASDAQ )

Price: $81.97
Change: +0.72 (0.89%)
Volume: 510.9 K
4:00PM ET 10/15/2019
 
 

Medicines Co ( NASDAQ )

Price: $53.09
Change: +0.90 (1.71%)
Volume: 1.0 M
4:00PM ET 10/15/2019
 
 

MyoKardia Inc ( NASDAQ )

Price: $54.81
Change: +1.51 (2.83%)
Volume: 235.2 K
3:59PM ET 10/15/2019
 
 

Portola Pharmaceuticals Inc ( NASDAQ )

Price: $27.43
Change: +0.57 (2.12%)
Volume: 576.3 K
3:59PM ET 10/15/2019
 
 

Intercept Pharmaceuticals Inc ( NASDAQ )

Price: $64.25
Change: +3.42 (5.62%)
Volume: 430.4 K
4:00PM ET 10/15/2019
 

Read more news Recent News

United Therapeutics Wins FDA Review of Treyvent Drug-Device Combo
6:26AM ET 9/11/2019 MT Newswires

United Therapeutics (UTHR) said Thursday the US Food and Drug Administration has accepted its new drug application for Trevyent as a treatment for...

Israel's CollPlant Raises $6.5 Million Through Convertible Loans, Stock Drops 6.5%
1:59PM ET 9/03/2019 MT Newswires

Israel's CollPlant (CLGN) said on Tuesday it is raising $6.5 million via convertible loans, with $2 million coming from its top shareholder, Ami Sagi, and...

Sector Update: Health Care Stocks Sliding Lower in Late Trade
3:53PM ET 8/20/2019 MT Newswires

Top Health Care Stocks JNJ -0.90% PFE -1.25% ABT -0.85% MRK -0.24% AMGN -1.20% Health care stocks added to their mid-day declines, with the NYSE...

Sector Update: Small Declines for Health Care Stocks
1:23PM ET 8/20/2019 MT Newswires

Top Health Care Stocks JNJ -0.82% PFE -0.71% ABT -0.07% MRK +0.25% AMGN -0.93% Health care stocks were narrowly lower, including a fractional...

Company Profile

Business DescriptionUnited Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. View company web site for more details
Address1040 Spring Street
Silver Spring, Maryland 20910
Phone+1.301.608.9292
Number of Employees860
Recent SEC Filing09/11/20198-K
Chairman & Chief Executive OfficerMartine A. Rothblatt
President & Chief Operating OfficerMichael Ian Benkowitz
CFO, Treasurer & Principal Accounting OfficerJames Christopher Edgemond
Secretary, Executive VP & General CounselPaul A. Mahon

Company Highlights

Price Open$81.26
Previous Close$81.25
52 Week Range$74.31 - 128.94
Market Capitalization$3.6 B
Shares Outstanding43.9 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement10/30/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$10.63
Beta vs. S&P 500N/A
Revenue$1.6 B
Net Profit Margin-7.69%
Return on Equity-4.52%

Analyst Ratings as of 10/02/2019

Buy
4
Overweight
0
Hold
5
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset